Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.88B |
| 2 |
Pfizer
PFE
|
+$1.41B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.17B |
| 4 |
Cisco
CSCO
|
+$1.1B |
| 5 |
Novartis
NVS
|
+$984M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.21B |
| 2 |
Adobe
ADBE
|
+$1.06B |
| 3 |
Stryker
SYK
|
+$955M |
| 4 |
Boston Scientific
BSX
|
+$695M |
| 5 |
Banco Santander
SAN
|
+$684M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.16% |
| 2 | Financials | 17.3% |
| 3 | Industrials | 10.45% |
| 4 | Healthcare | 9.91% |
| 5 | Energy | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares MSCI Japan ETF
EWJ
$22.1B
| $226M | 0.08% |
2,681,188
+178,131
| +7% | +$15.4M |
|
127
iShare MSCI Eurozone ETF
EZU
$9.65B
| $214M | 0.07% |
3,413,718
+78,450
| +2% | +$5.14M |
|
128
iShares Global Healthcare ETF
IXJ
$4.11B
| $212M | 0.07% |
2,261,257
-5,771,341
| -72% | -$565M |
|
129
EOG Resources
EOG
$77.5B
| $204M | 0.07% |
1,412,904
+63,788
| +5% | +$7.74M |
|
130
iShares Global Energy ETF
IXC
$2.77B
| $203M | 0.07% |
3,524,710
-11,204,783
| -76% | -$558M |
|
131
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
| $203M | 0.07% |
1,860,386
-93,858
| -5% | -$10.3M |
|
132
iShares US Financials ETF
IYF
$4.67B
| $202M | 0.07% |
1,717,595
-15,718
| -0.9% | -$1.95M |
|
133
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
| $201M | 0.07% |
3,367,747
-133,852
| -4% | -$8.02M |
|
134
Banco Bradesco
BBD
$37.9B
| $194M | 0.07% |
53,277,128
+350,585
| +0.7% | +$1.33M |
|
135
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.24B
| $172M | 0.06% |
3,030,700
-87,017
| -3% | -$5.06M |
|
|
136
Stryker
SYK
$133B
| $151M | 0.05% |
458,475
-2,658,808
| -85% | -$955M |
|
137
Nu Holdings
NU
$70B
| $150M | 0.05% |
10,422,671
+180,486
| +2% | +$2.93M |
|
138
Franklin FTSE Japan ETF
FLJP
$4.01B
| $149M | 0.05% |
4,108,118
+4,099,183
| +45,878% | +$152M |
|
139
MYR Group
MYRG
$5.15B
| $147M | 0.05% |
521,146
+49,440
| +10% | +$12.8M |
|
140
Applied Materials
AMAT
$398B
| $144M | 0.05% |
422,055
-33,022
| -7% | -$11.1M |
|
141
Powell Industries
POWL
$7.63B
| $139M | 0.05% |
770,745
-181,074
| -19% | -$29.6M |
|
142
Qualcomm
QCOM
$160B
| $139M | 0.05% |
1,077,311
-58,328
| -5% | -$8.51M |
|
143
Mercado Libre
MELI
$95.6B
| $137M | 0.05% |
79,217
+6,315
| +9% | +$12.2M |
|
144
ATI
ATI
$24.8B
| $134M | 0.05% |
924,521
+16,026
| +2% | +$2.23M |
|
145
IDEX
IEX
$17.3B
| $134M | 0.05% |
708,157
+52,570
| +8% | +$10.4M |
|
146
Onto Innovation
ONTO
$12.5B
| $133M | 0.05% |
649,981
-52,018
| -7% | -$10.6M |
|
147
Linde
LIN
$235B
| $131M | 0.04% |
264,179
+8,480
| +3% | +$4M |
|
148
Flowserve
FLS
$9.63B
| $131M | 0.04% |
1,777,830
-87,599
| -5% | -$6.94M |
|
149
NetEase
NTES
$84.4B
| $128M | 0.04% |
1,147,760
+35,476
| +3% | +$4.4M |
|
150
Evercore
EVR
$12.1B
| $127M | 0.04% |
424,719
+104,914
| +33% | +$34.4M |
|
Similar funds
Ken Fisher's Q1 2026 Portfolio in Review
As of Q1 2026, Ken Fisher held 1,133 positions worth $295B, up 0.65% from $293B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Fisher's Q1 2026 filing shows 116 new, 416 increased, 461 reduced and 117 closed positions. Its largest new stake was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M. The largest sale was Abbott, an estimated $1.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Ken Fisher's largest Q1 2026 buy was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M.
- Ken Fisher added most to AbbVie in Q1 2026, an estimated $1.88B increase.
- Ken Fisher's biggest Q1 2026 reduction was Abbott, cutting an estimated $1.21B.
- Ken Fisher fully exited Trip.com Group in Q1 2026, selling an estimated $175M.
- Ken Fisher's ten largest holdings make up 33% of its $295B portfolio in Q1 2026.
- Ken Fisher opened 116 new positions and closed 117 in Q1 2026.
- Ken Fisher's portfolio value rose 0.65% quarter-over-quarter to $295B.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.